Stock Rich List
#1602 on the rich list of 14,644 insiders

Daniel O'Day

Chairman & CEO at Gilead Sciences. Based in Foster City, California.

$91.9M
in disclosed stock, −$1.4M (−1.45%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
1602nd of 14,644
Companies held
1
Largest holding
GILD, 100.0% of total
Latest SEC filing
Nov 5, 2026

What the $91.9M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Gilead Sciences GILD
Common Stock
Directly551,683$166.53$91.9M100.0%Form 4, Nov 5, 2026

Share counts are the amounts Daniel O'Day reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 5, 2026SoldGILD9,810$175.17$1.7MView
Nov 4, 2026SoldGILD102,619$175.16$18.0MView
Nov 2, 2026SoldGILD1,600$167.40$268KView
Nov 2, 2026SoldGILD1,700$168.10$286KView
Nov 2, 2026SoldGILD1,904$169.27$322KView
Nov 2, 2026SoldGILD7,796$170.35$1.3MView
Nov 2, 2026SoldGILD2,000$171.06$342KView
Oct 30, 2026SoldGILD15,881$175.25$2.8MView
Oct 1, 2026SoldGILD12,000$147.72$1.8MView
Oct 1, 2026SoldGILD3,000$148.63$446KView
Sep 1, 2026SoldGILD1,600$147.51$236KView
Sep 1, 2026SoldGILD7,992$148.36$1.2MView
Sep 1, 2026SoldGILD5,408$149.38$808KView
Aug 3, 2026SoldGILD6,700$129.66$869KView
Aug 3, 2026SoldGILD600$131.34$79KView
Aug 3, 2026SoldGILD7,700$130.80$1.0MView
Jul 1, 2026SoldGILD11,900$126.09$1.5MView
Jul 1, 2026SoldGILD3,100$127.08$394KView
Jun 1, 2026SoldGILD10,900$131.10$1.4MView
Jun 1, 2026SoldGILD3,062$132.22$405KView
Jun 1, 2026SoldGILD1,038$132.97$138KView
Apr 28, 2026SoldGILD3,050$130.01$397KView
Apr 28, 2026SoldGILD6,950$128.79$895KView
Mar 27, 2026SoldGILD10,000$136.82$1.4MView
Feb 27, 2026SoldGILD3,481$144.04$501KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
1599Zhitao He
Director, Newegg Commerce. Diamond Bar, CA
$92.1M+$5.3M (+6.15%)
1600Joshua B. Cohen
Co-Chief Executive Officer, Amylyx Pharmaceuticals. Cambridge, MA
$92.0M−$1.5M (−1.58%)
1601Justin B. Klee
Co-Chief Executive Officer, Amylyx Pharmaceuticals. Cambridge, MA
$92.0M−$1.5M (−1.58%)
1602Daniel O'Day
Chairman & CEO, Gilead Sciences. Foster City, CA
$91.9M−$1.4M (−1.45%)
1603Rehan Jaffer
Director, Six Flags Entertainment. New York, NY
$91.8M+$541K (+0.59%)
1604Joseph P. Adams Jr.
CEO and Chairman, FTAI Aviation. New York, NY
$91.8M−$2.2M (−2.35%)
1605Douglas A. Pertz
Executive Chairman, The Brink's. Roswell, GA
$91.7M−$2.0M (−2.17%)

Other Gilead Sciences insiders

All GILD insiders

Questions

How much stock does Daniel O'Day own?

Daniel O'Day holds $91,871,770 in listed stock based on SEC filings and current prices, mostly Gilead Sciences (GILD). That ranks 1602nd on the Stock Rich List.

Is this Daniel O'Day's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Daniel O'Day last buy or sell stock?

The most recent open-market trade on file is a sale of 9,810 GILD shares on Nov 5, 2026 at $175.17.